Score Breakdown
Offering Ability
60
Cash Runway
40
Float Risk
100
Warrant Exposure
15
Convertible Debt
40
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise
model 18%
• Active ATM program with $100M remaining capacity
Market Data
Market Cap$51.92M
Shares Outstanding50.62M
Float2.62M
Cash$6.97M
Debt$106.0K
Short InterestN/A
Institutional Holdings
QoQ: ↓ 98.0% shares (2026Q1 vs prior)
2 institutional holders · 124.9K shares
#1
GOLDMAN SACHS GROUP INC
104.3K shares
#2
MORGAN STANLEY
20.5K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
No current FINRA short-interest record is available for this ticker.
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
xbrl
XBRL CONVERTIBLE
2025-12-31
4
INSIDER TRANSACTION
2026-04-09
4
INSIDER TRANSACTION
2026-04-08
4
INSIDER TRANSACTION
2026-04-02
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual NBY Dilution Snapshot
NovaBay Pharmaceuticals Inc (NBY) has a DilutionScore of 58/100, rated High dilution risk. Score date: August 28, 2026.
- Stored ATM program remaining capacity: $100.0M.
- Stored outstanding warrants: 363,523.
- Recent SEC activity tracked for NBY: xbrl on 2026-06-30; 4 on 2026-04-09; 4 on 2026-04-08.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: